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Abstract
Background: Zearalenone (ZEA) is a secondary metabolite produced by Fusarium species. ZEA was proved to exert a
wide range of unwanted side effects, but its mechanism of action, particularly at duodenum levels, remains unclear. In
our study based on the microarray technology we assessed the alteration of gene expression pattern Sus scrofa
duodenum which has been previously exposed to ZEA. Gene expression data was validated by qRT-PCR and
ELISA. The gene expression data were further extrapolated the results to their human orthologues and analyzed
the data in the context of human health using IPA (Ingenuity Pathways Analysis).
Results: Using Agilent microarray technology, we found that gene expression pattern was significantly affected
by ZEA exposure, considering a 2-fold expression difference as a cut-off level and a p-value < 0.05. In total, we
found 1576 upregulated and 2446 downregulated transcripts. About 1084 genes (764 downregulated and 751
overexpressed) were extrapolated to their human orthologues. IPA analysis showed various altered key cellular
and molecular pathways. As expected, we observed a significant alteration of immune response related genes,
MAPK (mitogen activate protein kinases) pathways or Toll-Like Receptors (TLRs). What captured our attention was
the modulation of pathways related to the activation of early carcinogenesis.
Conclusions: Our data demonstrate that ZEA has a complex effect at duodenum level. ZEA is able to activate not
only the immune response related genes, but also those relate to colorectal carcinogenesis. The effects can be
more dramatic when connected with the exposure to other environmental toxic agents or co-occurrence with
different microorganisms.
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Background
Zearalenone (ZEA) is a secondary metabolite produced
by certain species that belong to the genus Fusarium, a
common group of fungus species [1, 2]. These fungi are
common contaminants present is almost all types of
crops, including those used as feed for farm animal diets
as well as cereals consumed by humans [3–5]. The ZEA
mycotoxin has a particular way of exerting its effects by
interfering in the physiological estrogen signaling path-
ways, since its chemical structure is similar to that of the
estrogenic hormone 17-β-estradiol [6–8]. Among the
different farm animals, pigs proved to be highly sensitive
to the effects of ZEA mycotoxin via contaminated feed.
They are known to display various deleterious effects
caused by this mycotoxin, but, regardless of the estrogenic
activity of ZEA, many of the observed damages are,
presumably, not always mediated by the estrogen receptor
[9, 10]. Also, the histology, anatomy, physiology – and
consequently the pathology – of this species are very
similar to that of humans, making it a suitable model for
the study of various diseases and physio-pathological
processes [11, 12].
The intestine is the interface between the organism
and the whole exposome, so it interacts with the existent
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microflora and with the pathogenic agents that may
occur [13–15]. These particular tissues were chosen be-
cause, as part of the gastro-intestinal (GI) tract, they are
involved in the immune response and inflammation on
the one hand, and they are among the most exposed to
the action of the contaminants on the other hand. This
makes these organs suitable subjects for this microarray
profiling study [16–20].
The animal model used for this study is the pig, due to
the previously mentioned genetic similarity between Sus
scrofa and Homo sapiens. At the same time, pigs con-
sume high quantities of maize, a cereal which is very
prone to Fusarium mycotoxin contamination [21], and
which is also a raw material in the diet of humans. Such
studies are of particular interest because humans also
consume high quantities of different cereals which are,
many times, contaminated with various mycotoxins such
as ZEA [9, 22]. Even though there are regulations regarding
the maximum tolerated values of food contaminating
agents, including ZEA [23], some such toxins have shown
increased resistance to decontaminating procedures, and a
wide range of side effects [24, 25]. Therefore it is important
to acquire a better understanding of the influence that
ZEA has on the health of humans and their surrounding
environment.
Results
Evaluation of duodenal gene expression pattern
A significant supposition in many toxicological investi-
gations is that the molecular states of organisms indicate
their biological responses to a particular toxin, like in
our case ZEA mycotoxin. Using the Agilent microarray
technology, we found that gene expression was consider-
ably affected by ZEA at duodenum level, considering 2-
fold expression difference as a cut-off level and p-value
< 0.05. In total, we found 4023 transcripts with an al-
tered expression level, from which 1576 were upregu-
lated and 2446 downregulated. Sus scrofa is a key
mammalian model system for studying complex human
diseases and therefore it is useful to assess the impact of
the toxin on this model, then to extrapolate the gene ex-
pression profile and to analyze the data in the context of
human health. We were able to obtain the human ortho-
logues for about 1084 genes (764 downregulated and
751 overexpressed).
Microarray data validation by qRT-PCR
The obtained microarray data were validated by qRT-
PCR. Therefore four genes were selected (NFKB1, IL-6,
TNF-α and SOD2) and three housekeeping genes (ACTB,
GAPDH, B2M) were used for the normalization of the
data. qRT-PCR data confirm the microarray downregula-
tion expression of these genes, moreover it shows a good
correlation among them (Fig. 1).
The impact of ZEA exposure on cytokine protein
expression at duodenum levels
The microarray data displayed previously showed an
alteration of molecules involved in immune response.
Therefore, we assessed the protein level for IL-1β, IL-8,
IL-4 and TNF-α for cellular lysates. As it can be seen
from Fig. 2, we observed a downregulation of IL-1β, IL-
8, IL-4 at protein level as a response to ZEA exposure.
The level of TNF-α was under the limit of detection
provided by our method.
Network analysis
A primary goal of the study was to identify the possible
implications of the altered genes at cellular and molecu-
lar level, as well as the related functions and pathways
that might be mediated by ZEA (Table 1). To accom-
plish this objective in an unbiased manner, we per-
formed IPA analysis for all the genes with and altered
expression levels that were extrapolated to their human
orthologues. This facilitated the assessment of the po-
tential impact by analyzing the networks, biological
functions, and canonical pathways. Additional file 1:
Figure S1 presents the top canonical pathways, based on
the overlap value, and displays the genes related to the
alteration of Toll-Like Receptors (TLRs) and the acti-
vation of the inflammatory cytokine in parallel with
the alteration of the expression level for the adhesion
molecules. In Additional file 2: Figure S2 are empha-
sized the altered genes related to MAPK (mitogen acti-
vate protein kinases), an early event of carcinogenesis,
fact demonstrated in Additional file 3: Figure S3. Also,
we observed alterations in GAP junction signaling
(Additional file 4: Figure S4).
The analysis of probe sets that are differentially
expressed with a fold change greater than 2 revealed 24
altered pathways, specific for the toxin exposure. Most
of the altered networks were related to the alteration of
normal cell status, the most significant network con-
taining 34 focus molecules (Fig. 3), with the core of this
network being the FOS gene. Another interesting network
is that represented by the one with the ID7 (Table 2), re-
lated to carcinogenesis, cell death and organism damage
(Figs. 3 and 4 ), the core or this network being represented
by ER. A curious aspect of the gene expression alteration
at duodenum level is represented by the network with the
ID20 (Table 1), where the core of the network is the RB1
gene; this gene is recognized to be involved in TGFB1 or
p53 signaling cell cycle regulation, but also to be related to
mitochondrial damage.
Discussion
ZEA mycotoxin is absorbed up to 90 % in the upper part
of the GIT (gastrointestinal tract), and it goes into en-
terohepatic circulation as other mycotoxins [26]. One of
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the important roles of the GIT is its function as an im-
mune barrier. This function is accomplished through a
number of particularities. Firstly, it possesses its own
immune system and it is estimated that up to 70 % of
the immune defenses of the organism are located in the
intestine. Secondly, its morphology plays a role as a
physical barrier through tight junctions (TJs) formed
mainly from occludin and claudin isoforms proteins, and
gap junctions (GJs) that permit the transfer of ions,
nucleotides and other small molecules between adjacent
cells, and are formed mainly by connexins. Last but not
least, the intestinal microbiota plays a very important
role in protecting against pathogen invasion [27]. More-
over, the physical barrier can be disrupted due to defective
TJs and GJs. ZEA has been shown to reduce mRNA levels
of occludin and claudin-4 and also the protein levels of
connexin [28], a mechanism that is altered by cytotoxic
and carcinogenic agents [29], fact demonstrated also by
present study, via multiple mechanisms relate to cell-to-
cell communication.
Fig. 1 qRT-PCR data validation of the microarray data
Fig. 2 Protein expression quantification by ELISA at duodenum level for IL-1B, IL-8 and IL-4 for the control group and the group exposed to ZEA
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By quantifying the modified expression of tens of
thousands of genes, we can recognize mechanistically-
relevant genes, leading to a better understanding of the
ZEA toxicological effects at duodenum level.
ZEA was proved to affect the alteration of several
genes involves in inflammatory response, oxidative
stress, proteinases or other relevant genes [30]. The
capacity to activate oxidative stress was proved also in an
in vitro study [31]. It was reported that ZEA has pro-
apoptotic effects, by increasing the Bax/Bcl-2 ration [32].
ZEN was observed to be involved in hepatic injury via
Nrf2/ARE signaling pathway [33], mechanism altered also
at intestinal level. Therefore, continuous exposure might
be related to the activation of the tumor-promoting in-
flammatory mechanisms [30], expressed by the inflamma-
tory cytokines or by the antioxidant enzyme, these being
validated by qRT-PCR. It is clear that ZEA leads to an in-
flammatory microenvironment, and this can be correlated
with increased mutation rates, all these representing early
carcinogenic events. This fact sustained by other environ-
mental toxic agents can be an essential in the activation of
tumor initiation [34]. In the case of HCT116 cells it was
observed that even at low concentration ZEA increase cell
proliferation, colony formation and cell migration [35].
Table 1 Top 4 canonical pathway targeted by ZEA at
duodenum level
Canonical pathway p-value Overlap
1 TREM1 Signaling 1.45E-06 26.7 % 20/75
Dopamine-DARPP32 Feedback in
cAMP Signaling
5.22E-06 19.3 % 31/161
2 Cancer Regulation by Stathmin1 4.29E-06 18.3 % 35/191
3 Role of Macrophages, Fibroblasts and
Endothelial Cells in Rheumatoid Arthritis
1.81E-08 18.1 % 54/298
4 Protein Kinase A Signaling 1.63E-06 15.3 % 59/385
Fig. 3 Gene network interaction generated using IPA, as response to ZEA exposure at duodenul level, as key central molecule is FOS, being relate
to oxidative stress response and TGFB1 pathways. The altered expressed genes are displayed in red and green, based on fold change expression
level, meanwhile the gene in grey are retrieved in literature to interact
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ZEA compounds were observed to exert estrogenic
effects [7, 36], even at nM concentration [36], fact con-
firmed by the present study. The estrogenic effects seem
to be altered via Erk1/2 phosphorylation, mechanism, in
parallel with the sustaining of cell proliferation [36].
ZEN could promote the autocrine action or expression
of the ghrelin gene in piglet ovary [37].
Other studies confirmed the activation of MAPK and
oxidative stress related genes as response to ZEA in
MCF-7 breast cancer cells, [38] and macrophages [31],
this findings being confirmed by this present in vivo
study at duodenum level. The oxidative species seems to
be generated via p53, JNK or p38 pathways [31, 39]. In
our study NFKB1 was found to be down-regulated, also
it was connected with a proapoptotic effect in colon car-
cinoma cells. c-Myc is an early response gene with im-
portant regulatory functions in the cell cycle, and known
to be regulated in colon cancer. c-Myc was downregu-
lated by ZEA exposure. In the same time, the IPA net-
work analysis showed the complex action of ZEA, the
analysis being more focused on the alteration of the
mitochondrial pathways connected with endocrine dys-
function [40]. There are several classes of altered genes,
such as Ras-related genes, kinases/phosphatases and
their binding proteins, genes retrieved also in study.
These Ras pathways contribute to cell growth and pro-
liferation [36].
Alteration of Stathmin1 pathways are connected with
invasion and migration capacity in digestive cancers
[41]. The oncogenic role of the Stathmin1 pathways was
proved to be related via miR-223 [42]. In a recent review
paper Reuter et al., (2010) present a clear connection
between oxidative stress and the activation of the tran-
scription factors (NFkB, AP-1, HIF-1α, PPAR-γ, Wnt and
Nrf2) [43]. The present study confirms that the activation
of these transcription factors is related to the alteration
of other multiple genes like growth factors, cytokines/
chemokines, cell cycle related genes, cell proliferation
or differentiation anti-inflammatory molecules, or those
in invasion and migration. From the top 10 genes that
were highly expressed in the case of duodenum exposure
to ZEA, a representative one is CTNNA1. CTNNA1,
Table 2 Top disease and function altered as response to ZEA exposure
ID Top diseases and functions Score Focus molecules
1 Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance 40 34
2 Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities 38 33
3 Auditory Disease, Hereditary Disorder, Neurological Disease 38 33
4 Molecular Transport, Hereditary Disorder, Connective Tissue Disorders 35 32
5 Digestive System Development and Function, Endocrine System Development and Function, Organ Morphology 31 30
6 Cellular Movement, Cell-To-Cell Signalling and Interaction, Nervous System Development and Function 31 30
7 Cancer, Cell Death and Survival, Organismal Injury and Abnormalities 31 30
8 Gene Expression, Protein Synthesis, RNA Post-Transcriptional Modification 29 29
9 Cell Death and Survival, Cell Morphology, Infectious Disease 29 29
10 Cardiovascular System Development and Function, Cancer, Cardiovascular Disease 29 29
11 Connective Tissue Disorders, Immunological Disease, Inflammatory Disease 28 28
12 Tissue Development, Post-Translational Modification, Cell Cycle 28 28
13 Cell Cycle, DNA Replication, Recombination, and Repair, Cellular Compromise 26 27
14 Nucleic Acid Metabolism, Small Molecule Biochemistry, Cell Cycle 26 27
15 DNA Replication, Recombination, and Repair, Cell Cycle, Reproductive System Development and Function 26 27
16 Cellular Growth and Proliferation, Embryonic Development, Organ Development 26 27
17 RNA Post-Transcriptional Modification, Developmental Disorder, Hereditary Disorder 26 27
18 Developmental Disorder, Hereditary Disorder, Skeletal and Muscular Disorders 26 27
19 Protein Synthesis, Cancer, Organismal Injury and Abnormalities 26 27
20 Energy Production, Lipid Metabolism, Small Molecule Biochemistry 26 27
21 Cellular Assembly and Organization, Inflammatory Disease, Inflammatory Response 24 26
22 Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry 24 26
23 RNA Post-Transcriptional Modification, Carbohydrate Metabolism, Cellular Compromise 24 26
24 Amino Acid Metabolism, Small Molecule Biochemistry, Cell Signaling 24 26
25 Infectious Disease, Organismal Injury and Abnormalities, Dermatological Diseases and Conditions 24 26
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along with other MAPK related genes [31, 39], have been
proved to be involved in gastric cancer [44]. NFAT-
signaling pathway activation was proved to be implicated
in aggressive forms of inflammatory pathologies. More-
over, this pathway was proved to have a significant role in
inflammatory breast cancer [45].
The results remains to be further investigated particu-
lar on ZEA derivatives, a recent study present antitu-
moral effects of the semisynthetic zearalenone analogues
[46]. Therefore the mechanisms of transformation and
detoxification in parallel with the combinatorial effect
need to be taken in account [47]. The procarcinogenic
effect of ZEA was also studied by Ouanes et al., 2003
[48], and should take into account the accumulation in or-
ganism and the time required for metabolisation of this
toxins [49]. Novel monitoring method based on urinary
excretion of ZEA metabolites should be developed [50].
Policies and regulations of the mycotoxin need to be
assessed in the context of the exposome exposure, not
only guided by compound exposure and evaluation of
the dose-response analyses in risk assessment [51, 52].
The impact of mycotoxins on human health needs to be
considered in a transformative mode to take into ac-
count the whole exposome exposure [52]. Even in the
case of a single toxic exposure (ZEA), the effect on gene
expression is significant at duodenum level. There are
several clues that environmental toxic exposure implies
[51], including the case of ZEA. This toxin can interact
and affect more dramatically health status that is pre-
sented by microarray data. ZEA is only one component
Fig. 4 Gene network interaction generated using IPA, as response to ZEA exposure at duodenum level, as key central molecule is RB, being relate
to alteration of the cell cycle or NFkB pathways. The altered expressed genes are displayed in red and green, based on fold change expression
level, meanwhile the gene in grey are retrieved in literature to interact
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of the exposome, therefore ZEA toxic effects can be
more dramatic in the context of multiple exposures.
Conclusion
As ZEA caused alteration of gene expression, chronic
exposure can create a metabolic environment that allows
mutated cells to acquire a selective advantage. Our data
demonstrate that ZEA activates not only the immune
related genes response, but also those related to car-
cinogenesis. The effect can be more dramatic when is
connected with other environmental toxic agents and
this should be taken into account for further imple-
mentation of novel norms for the control of this toxin.
Methods
Animals and treatments
Two groups of weaned TOPIG piglets [(Landrace ×
Large White) × (Duroc × Pietrain)], n = 6 per group/pen)
with an initial average body weight of 9.88 ± 0.2 Kg and
derived from the experimental farm of the National
Research Institute for Biology and Animal Nutrition,
Balotesti Romania were used in this study. The animals
individually identified by ear tag were housed in pens
and fed with experimental diets: a control diet without
mycotoxin or a diet contaminated with ZEA (100 ppb)
for 30 days. Assigned diet and water were provided ad
libitum every day of the experiment. Pigs were observed
twice daily and no clinical signs or death was recorded
throughout the entire experimental period. At the end of
the experiment, animals were stunned and slaughtered
in an EU-licensed abattoir according with the EU Council
Directive 2010/63/CE. Organ samples were collected on
ice from all animals, weighed and were stored at –80 °C
until the analyses.
Animals were raised in agreement with the Romanian
Law 43/2014 for handling and protection of animals
used for experimental purposes and the EU Council
Directive 98/58/EC concerning the protection of farmed
animals. The study protocol was accepted by the Ethical
Committee of the National Research-Development Insti-
tute for Animal Nutrition and Biology, Balotesti, Romania
(Ethical Committee no. 52/2014). At the end of the re-
search period, animals were stunned and slaughtered in
an EU-licensed abattoir in accordance with the EU
Council Directive 2010/63/CE.
RNA extraction and quality control
The duodenum tissue collected from weaned pigs ex-
posed to ZEA for 33d was disrupted using a mechanical
homogenizer, in the presence of TRI Reagent (Sigma-
Aldrich), and the total RNA was extracted following the
phase separation protocol with chloroform and isopro-
panol, according to the manufacturer’s protocol. The
RNA thus obtained underwent a further purification
step with the RNeasy Micro Kit from Qiagen, which
uses silicagel spin columns to generate high quality
RNA from small quantities of tissue. The precise con-
centrations and integrity of extracted nucleic acids, ne-
cessary for the subsequent microarray step were then
evaluated using the NanoDrop2000 (Thermo Scientific)
and the Bioanalyzer 2100 (Agilent Technologies).
Microarray
The microarray probes were synthesized from equal
quantities of 100 ng of total RNA, by using Agilent Low
Input Quick Amp Labeling Kit (5190-2305) according to
the manufacturer’s protocol. Subsequent to this step, the
hybridization products were purified using RNeasy Mini
kit (Qiagen). Probe quality control was executed using the
NanoDrop2000 spectrophotometer (Thermo Scientific),
all the samples having a specific activity higher than 6
pmol/μl Cy3/μg cRNA (specific activity > 8 pmol Cy3/μg
cRNA). The fragmentation and hybridization were per-
formed based on the Agilent one color protocol.
The samples were hybridized (17 h at 65 °C) on a cus-
tom microarray slide using SureDesign, containing up of
60mer oligos for over 59,000 probes representative for
a high number of Sus scrofa transcripts (AMADID
056850). The microarray slides were scanned with the
SureScan Microarray Scanner (1x60k array slides with
61 × 21 mm, resolution 3 μM) from Agilent and the
images were processed with Feature Extraction 11.0.1.1
software. GeneSpring GX v.13.0 from Agilent was used for
data analysis, which started with the removal of control
probes and quantile normalization. A threshold of 2.0 was
applied for the fold change, and then the moderated t test
was used, together with the FDR (False Discovery Rate)
correction method and extrapolated to human as des-
cribed by Petric et al. [53].
The information related to homology annotation for
all the transcripts sequence for S. scrofa and humans
was used NCBI database (www.ncbi.nlm.nih.gov) and
BLAST. The analysis in the context of human health for
the altered genes as response to ZEA exposure was done by
ingenuity pathway analysis (IPA; htp://www.ingenuity.com).
qRT-PCR data validation
For the validation of the gene profiles provided by micro-
array analysis, the expression levels of five randomly se-
lected genes: TNF-α (Tumor Necrosis Factor α), IL-8
(Interleukin 8), IL-6 (Interleukin 6), IL-1β (Interleukin 1
beta), IL-10 (Interleukin 10) and NFkB1 (nuclear factor of
kappa light polypeptide gene enhancer in B-cells 1) were
measured by real time RT-qPCR in all samples used for
microarray analysis. 1 μg of total RNA extracted from
each sample was used to generate cDNA using M-MLV
Revers Trascriptase kit (Invitrogen, Life Technologies),
according to the manufacturer’s recommendations.
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Quantitative fluorescent real-time PCR reactions were
set up in a total volume of 20 μl using 10 μl of cDNA
(diluted 1:10 with nuclease-free water), SYBR Green PCR
Master Mix (Applied Biosystems, Life Technologies),
0.3 μM each of gene-specific primer and performed in the
Rotor- Gene-Q (QIAGEN GmbH, Germany) machine.
The primer pairs used in the present study, listed in
Table 3, were obtained from Eurogentec (San Diego,
USA). The cycling conditions were set up according to
manufacturer’s recommendation, as follows: UDG pre-
treatment at 50 °C for 2 min, initial denaturation step
at 95 °C for 15 s, followed by 40 cycles of 95 °C for
15 s, 60 °C for 60s with a single fluorescence measure-
ment. The specificity of the PCR products was confirmed
by analysis of the dissociation curve. The melting curve
programme consisted of temperatures between 60 and
95 °C with a heating rate of 0.1 °C/s and continuous
fluorescence measurement. Negative controls were used
for each primer pair. The relative quantification of gene
expression changes were quantified using the compara-
tive method. The expression levels of two reference
genes, GAPDH and β-actin were used for data normalisa-
tion. These reference genes were experimentally validated
for duodenum tissues and the lack of treatment effect and
expression variation was the criteria for reference gene
choice. The results were expressed as relative fold change
(Fc) in comparison with control samples.
Cytokine concentration evaluation (ELISA)
Organ lysate was prepared as described by Taranu et al.,
(2014) [10] and cytokine concentrations in the supernatant
were determined by ELISA. Briefly, the purified fraction of
anti-swine cytokines (IL-1β, IL-8, IL-4) were used as cap-
ture antibodies in conjunction with biotinylated anti-swine
antibodies (R&D system). Streptavidin-HRP (Sigma) and
TMB (Sigma) were used for detection. Absorbance was
read at 450 nm using an ELISA plate reader (Tecan,
Sunrise, Austria). Recombinant swine cytokine proteins
were used as standard and results were expressed as pico-
grams of cytokine/mL.
Additional files
Additional file 1: Figure S1. Alteration of Toll-Like Receptors (TLRs) and
the activation of the inflammatory cytokine in parallel with the alteration
of the expression level for the adhesion molecules as response to ZEA
exposure; pathway generated using IPA (Ingenuity Pathway Analysis).
(JPG 5492 kb)
Additional file 2: Figure S2. Alteration of genes related to MAPK
(mitogen activate protein kinases), an early event of carcinogenesis, fact
demonstrated as response to ZEA exposure; pathway generated using IPA.
(JPG 2327 kb)
Additional file 3: Figure S3. Activation of colorectal carcinogenic
mechanism as response to ZEA exposure; pathway generated using IPA.
(JPG 5802 kb)
Additional file 4: Figure S4. Alterations in GAP junction signaling with
signification on the increasing the susceptibility to bacterial infection;
pathway generated using IPA. (JPG 2711 kb)
Abbreviations
ACTB, Beta-actin; AP-1, Activator protein 1; ARE, antioxidant response
element; B2M, Beta-2-Microglobulin; Bax, BCL2 Associated X Protein; Bcl-2,
B-cell lymphoma 2; CTNNA1, Catenin Alpha 1; ER, Estrogen Recptor; Erk1/2,
extracellular signal–regulated kinases 1/2; FDR, False Discovery Rate;
GAPDH , Glyceraldehyde-3-Phosphate Dehydrogenase; GAPDH,
Glyceraldehyde-3-Phosphate Dehydrogenase; GIT, gastrointestinal tract;
Table 3 qPCR primer sequences and characteristics
Gene Accesion no. Primer source Primer sequence (5′→ 3′) Orientation Tm (°C) Amplicon lenght (bp) References
TNF-α NM_214022 Pig ACTGCACTTCGAGGTTATCGG forward 60 118 [54]
GGCGACGGGCTTATCTGA reverse 60
IL-8 NM_213867.1 Pig GCTCTCTGTGAGGCTGCAGTTC forward 58 79 [54]
AAGGTGTGGAATGCGTATTTATGC reverse 54
IL-6 NM_214399 Pig GGCAAAAGGGAAAGAATCCAG forward 57 87 [54]
CGTTCTGTGACTGCAGCTTATCC reverse 61
IL-1β NM_214055 Pig ATGCTGAAGGCTCTCCACCTC forward 62 89 [55]
TTGTTGCTATCATCTCCTTGCAC reverse 59
IL-10 NM_214041.1 Pig GGCCCAGTGAAGAGTTTCTTTC forward 54 51 [54]
CAACAAGTCGCCCATCTGGT reverse 55
NFkB1 NM_001048232.1 Pig TCGCTGCCAAAGAAGGACAT forward 54 101 [55]
AGCGTTCAGACCTTCACCGT
GAPDH NM_001206359.1 Pig ACTCACTCTTCTACCTTTGATGCT forward 49 100 [54]
TGTTGCTGTAGCCAAATTCA reverse 56
B-actina NM_213978.1 Pig GGACTTCGAGCAGGAGATGG forward 60 230 [56]
GCACCGTGTTTGCGTAGAGG reverse 62
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GJs, gap junctions; HIF-1α , Hypoxia-inducible factor 1-alpha; IL-10, Interleukin
10; IL-1β, Interleukin 1 beta; IL-4, Interleukin 4; IL-6, Interleukin 6; IL-8, Interleukin
8; IPA, Ingenuity Pathways Analysis; JNK, Jun amino-terminal kinases; MAPK,
mitogen activate protein kinases; NFAT, Nuclear factor of activated T-cells;
NFKB1, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1;
Nrf2, nuclear erythroid 2-related factor 2; PPAR-γ, Peroxisome Proliferator-
activated Receptor γ; RB1, retinoblastoma; SOD2, Superoxide dismutase 2;
TGFB1, Transforming Growth Factor Beta 1; TJs, tight junctions; TLRs - Toll-
Like Receptors; TNF-α, Tumor Necrosis Factor α; ZEA, Zearalenone
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